NMTC - FIGS FWBI and ATXI among pre market gainers
2023-03-09 08:40:39 ET
- Ocean Biomedical ( OCEA ) +38% on sharing detailed research data on anti-tumor pathway discoveries and their potential for treatment of non-small cell lung cancer, metastatic melanoma, and glioblastoma by scientific co-founder.
- First Wave ( FWBI ) +25% announces first patient dosed in Phase 2 SPAN clinical trial of enhanced adrulipase formulation.
- BYND Cannasoft Enterprises ( BCAN ) +21% .
- Unicycive Therapeutics ( UNCY ) +20% .
- Asana ASAN +17% on Q4 earnings.
- Avenue Therapeutics ( ATXI ) +14% .
- AcuityAds Holdings ATY +14% on Q4 earnings.
- Build-A-Bear Workshop BBW +12% on Q4 earnings.
- Clene CLNN +12% after new data for lead asset in ALS study.
- Cassava Sciences SAVA +11% on director's ~$2.3M share purchases.
- NeuroOne Medical Technologies ( NMTC ) +9% .
- Summit Therapeutics SMMT +9% on Q4 earnings.
- Solo Brands DTC +8% on Q4 earnings.
- FIGS ( FIGS ) +6% .
- Emergent BioSolutions EBS +5% after institutional investor, hedge fund buys.
For further details see:
FIGS, FWBI and ATXI among pre market gainers